Role of Intravenous Calcium to Decrease Blood Loss During Intrapartum Cesarean Section (NCT07550413) | Clinical Trial Compass
Not Yet RecruitingPhase 2
Role of Intravenous Calcium to Decrease Blood Loss During Intrapartum Cesarean Section
Pakistan182 participantsStarted 2026-05
Plain-language summary
To determine the effectiveness of prophylactic intravenous calcium chloride administered after cord clamping in reducing postpartum blood loss during intrapartum cesarean section.
Who can participate
Age range18 Years – 45 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Women aged 18-45 years undergoing intrapartum cesarean section at ≥34 weeks of gestation.
* Exposure to oxytocin during labor before CS.
* Singleton pregnancy with no known fetal anomalies.
Exclusion Criteria:
* Known bleeding disorders or preoperative coagulation abnormalities
* Preeclampsia or hypertensive disorders contraindicate calcium use.
* History of cardiac disease or arrhythmias
* Placental abnormalities, i.e., placenta previa, accreta
* Emergency CS with fetal distress or cord prolapse.
* Known hypersensitivity to calcium chloride.